Zeldis, Jerome B.,Schafer, Peter H.,Rohane, Patricia E. W.
申请号：
AU2013200555
公开号：
AU2013200555A1
申请日:
2013.01.31
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
#$%^&*AU2013200555A120130221.pdf#####ABSTRACT Methods of treating cutaneous lupus in a human are disclosed. Specific methods encompass the administration of (+)-2-[-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]45 acetylaminoisoindoline-1,3-dione, 4-(amino)-2-(2.6-dioxo(3-piperidyl))-isoindoline-1,3-dione (ACTIMID TM), 3-(4-amino-I-oxo1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione (REVLIMID*), or cyclopropyl 2-[(1S)-1-(3ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindolin4-yl] carboxamide, alone or alternatively, in combination with a second active agent. 10 C: pord\SPEC-832221.docx
